Cellectar Biosciences Inc

NASDAQ CLRB

Data sourced from iex and EODHD
Download Data

Cellectar Biosciences Inc Cash Flow Statement 2005 - 2024

This table shows the Cash Flow Statement for Cellectar Biosciences Inc going from 2005 until 2024. The cash flow statement is a financial statement that shows the inflow and outflow of cash and cash equivalents from a company's operating, investing, and financing activities over a specified period. It provides crucial information about a company's ability to generate and manage cash, which is essential for its day-to-day operations, investments, and debt obligations.
Cash Flow Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31
Net Income
M -22 -7 -14 -8 -9 -7 -8 -7 -6 -6 -6 -6 -6 -4 -4 -4 -4 -3 -4 -3 -4 -4 -3 -3 -3 -4 -3 -3 -3 -3 -2 -2 1 1 -2 -2 -2 -3 -1 -2 -3 -4 -1 -2 -3 -2 -2 -2 -2 -2 -2 -3 -1 -1 -1 -1 5 -13 -3 -5 -2 -2 -3 -5 -7 -7 -6 -4 -2 -3 -3 -1 -1 -1 -1 -1 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Non-Cash Items (Other)
M 12 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 -2 -2 -2 -2 -2 -2 -2 1 0 0 0 -8 9 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
Operating Cash Flow
M -13 -10 -8 -8 -7 -7 -7 -6 -5 -5 -6 -7 -5 -4 -4 -3 -4 -3 -4 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -2 -2 -2 -2 -1 -2 -2 -2 -2 -2 -2 -3 -3 -3 -2 -2 -2 -2 -1 -2 -2 -2 -2 -1 -1 -1 -2 -3 -2 -2 -2 -3 -3 -4 -6 -4 -4 -4 -3 -2 -2 -2 -1 -1 -1 -1 -1 0
Capital Expenditures
M 0 0 -1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Acquisitions
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Investing Activities
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - -
Investing Cash Flow
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 2 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - - - - - -
Repayment/Issuance of Debt (Net)
M - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 4 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Equity Repurchase (Common, Net)
M - 0 - - - - - - - - - 0 1 -18 0 18 - 9 9 9 - 0 15 0 0 1 0 0 3 8 0 8 0 0 0 0 0 0 12 0 0 0 0 0 0 0 0 0 32 32 5 5 - - - - - - - - - - - - - - - - - - - - - - - - -
Dividends Paid
M - - - - - - - - - - - - - - - - - - - - - 2 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 5 - - - 1 2 - - 2 1 - - 0 0 1 0 0 0 0 0 0 - - - -
Other Financial Activities
M 0 1 0 - 0 0 0 0 0 0 0 0 1 1 0 18 0 -9 0 9 0 -7 15 0 0 3 0 0 3 3 0 8 0 0 0 0 0 1 0 0 4 0 2 0 0 1 0 0 0 0 0 4 4 0 1 0 1 2 3 0 2 6 0 -1 0 -14 1 14 0 0 -2 0 0 0 -1 3 0
Financing Cash Flow
M 0 1 0 - 0 0 0 0 0 0 0 0 1 1 0 18 0 -9 0 9 0 -7 15 0 0 3 0 0 3 3 0 8 0 0 0 0 0 1 0 0 4 0 2 0 0 1 0 0 0 0 0 4 4 0 1 0 1 2 3 0 2 6 0 -1 0 -14 1 14 0 0 -2 0 0 0 -1 3 0
Exchange Rate Adjustment
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Beginning Cash
M 10 19 5 13 20 18 25 31 36 40 47 54 57 19 22 7 11 13 17 10 13 16 4 7 10 6 8 11 11 6 8 2 4 2 5 7 9 12 2 4 2 5 6 8 5 6 7 4 6 2 3 1 3 3 3 6 9 6 4 7 1 4 6 7 10 15 19 8 10 12 16 17 4 5 2 0 0
Ending Cash
M 40 10 19 5 13 20 18 25 31 36 40 47 54 57 19 22 7 11 13 17 10 13 16 4 7 10 6 8 11 11 6 8 2 4 2 5 7 9 12 2 4 2 5 6 8 5 6 7 4 6 2 3 2 2 3 3 6 9 6 4 7 1 4 6 7 10 15 19 8 10 12 16 17 4 5 2 0
Stock-Based Compensation
M 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 - 0 0 0 0 0 0 0 0 - - 0 1 - - 0 1 - - 0 - 0 0 -
Issuance/Purchase of Shares
M - 0 - - - - - - - - - 0 1 -18 0 18 - 9 9 9 - 0 15 0 0 1 0 0 3 8 0 8 0 0 0 0 0 0 12 0 0 0 0 0 0 0 0 0 32 32 5 5 - - - - - - - - - - - - - - - - - - - - - - - - -
Capital Stock Change
M - 0 - - - 10 0 - - 0 0 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Working Capital
M 25 -2 4 -1 7 15 12 20 27 33 38 44 49 54 16 20 5 9 12 16 9 12 14 3 6 9 5 8 11 11 5 7 -1 -2 -3 -1 1 8 10 -2 0 -2 1 0 2 4 5 7 4 5 2 3 2 2 -3 -2 0 -8 -1 -3 2 -5 -3 -3 -3 4 11 18 8 11 13 16 17 5 5 1 0
Free Cash Flow
M -13 -10 -9 -8 -7 -8 -7 -6 -5 -5 -6 -7 -5 -4 -4 -3 -4 -3 -4 -3 -3 -3 -3 -3 -3 -3 -3 -3 -3 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -2 -3 -3 -3 -2 -2 -2 -2 -2 -2 -2 -2 -2 -1 -1 -1 -2 -3 -2 -2 -2 -3 -3 -4 -6 -4 -4 -4 -3 -2 -2 -2 -1 -1 -1 -1 -1 0

StockViz Staff

September 20, 2024

Any question? Send us an email